Research study Program year 2023 Source: CMS Open Payments

Scgam-06

Research payments

$312,266

105 payments

Through program year 2023, $312,266 in research payments was reported against Scgam-06, across 105 payments, paid by Octapharma USA, Inc..

Paid by: Octapharma USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$20,175	6
2022	Research	$105,017	23
2021	Research	$187,074	76

Breakdown

Who paid Research payments · program years 2021–2023

Octapharma USA, Inc. $312,266 105 payments

Who received the money Research payments · program years 2021–2023

University of South Florida Organisation paid for research $48,100 16 payments
Midlands Pediatrics Organisation paid for research $29,610 7 payments
Allergy Partners Of Western North Carolina Organisation paid for research $20,906 11 payments
Georgia Pollens Clinical Research Organisation paid for research $20,510 7 payments
Bellingham Asthma Allergy And Immunology Clinic Organisation paid for research $18,445 9 payments
The Regents Of University Of California Organisation paid for research $17,944 2 payments
Clinical Trial Source LLC Organisation paid for research $16,031 3 payments
Allergy Asthma & Immunology Organisation paid for research $14,720 2 payments
Allergy And Clinical Immunology Associates Organisation paid for research $12,421 4 payments
Washington University Organisation paid for research $11,422 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.